serena williams promoting glp-1 Shares Her Weight Loss Journey With Company Ro Serena Williams on Taking a

Mann JFE, et al

No, youve just stopped working against aging and its caught it up with you, as it naturally will

(2025) Available online at: [Accessed May 2, 2025] 36

K.) Plant organelles: compartmentation of metabolism in photosynthetic cells 229263 (Cambridge, 1992a)

So here are some takeaways on the longevity of the obesity platform: Even without GLP-1 craze they grew the business (profitably?) to a $100M run-rate in 7 months with oral weight loss medications alone We will see a flood of new GLP-1 medications enter the market and the situation will move quickly and be fluid including the introduction of oral compounds that may lead to other use-cases for Hims There is some sort of precedent that compounding certain elements like end-dosage or side effect mitigation is considered clinically necessary and therefore defensible Hims & Hers will also offer brand-name GLP-1s on platform, maybe alluding to expectations of reduction in out of pocket cost over time, or an increase in supply My unsolicited thoughts for Hims would be to take advantage of this huge surge in cash and invest it into the sustainable, growing parts of the business

Abbreviations GSH: Glutathione PAL: Phenylalanine ammonia-lyase CAD: Cinnamyl alcohol dehydrogenase POD: Peroxidase PG: PGSC0003DMG40 SA: Salicylic acid IAA: Indole-3-acetic acid (auxin) JA: Jasmonic acid qRT-PCR: Quantitative real-time polymerase chain reaction References Liu R, Zhang ZH, Chen SJ, Wang ZH